OmniAb Investor Conference Presentation Deck
November 2022, 43 slides
  1. OmniAb
  2. Related Decks
  3. Investor Conference Presentation Decks
credit annual conference | OmniAb
disclaimer | OmniAb
our business model is focused on licensing our proprietary discovery technology we are meeting a global industry need poised for growth | OmniAb
mission our mission is to enable the rapid development of innovative therapeutics by pushing the frontiers of drug discovery technologies | OmniAb
the platform create diverse antibody pools screen antibody candidates identify the right antibody dal | OmniAb
antibodies and industry demand | OmniAb
the platform | OmniAb
what is biological intelligence we believe that antibodies generated in are superior to ones from other sources because they are naturally optimized through an iterative process that preferentially selects for antibodies with excellent specificity and developability profiles the ability of the immune system in our engineered animals to create optimized antibodies for human therapeutics is what we call biological intelligence we believe this approach increases the efficiency and probability of success of therapeutic antibody discovery and may help limit the attrition of antibody product candidates in the clinic | OmniAb
the platform antibody generation technologies | OmniAb
rodent platforms | OmniAb
greater evolutionary distance yields greater immunogenicity and more antibody diversity | OmniAb
create novel binding domains | OmniAb
common light chain platforms for antibodies yet i a | OmniAb
antibody repertoires | OmniAb
screening platforms | OmniAb
the platform ree ort auto | OmniAb
ion channels and transporters | OmniAb
leveraging biological intelligence with computational tools | OmniAb
history | OmniAb
growth of partner programs | OmniAb
antibody repertoire source used | OmniAb
diverse drug formats and modalities a a | OmniAb
select partners | OmniAb
key performance indicators oes | OmniAb
intellectual property advantage all | OmniAb
business model license partnerships designed to include and collaboration access fees milestones royalties on commercial sales | OmniAb
illustrative revenue profiles for successful partnered programs weighted towards downstream success | OmniAb
illustrative antibody deal structure profile a profile | OmniAb
published probability of success and for antibodies | OmniAb
building blocks of value novel platform technologies | OmniAb
revenue | OmniAb
cash position provides long operational runway business is close to break even cash flow recent transaction provides sufficient capital to fund operations for foreseeable future | OmniAb
share information at time of split rota snares stock must trade for out | OmniAb
management | OmniAb
board of directors | OmniAb
our key areas of focus going forward on | OmniAb
summary | OmniAb
for more information please visit | OmniAb
approved and clinical stage partner pipeline | OmniAb
recent news flow from partners | OmniAb
| OmniAb
the second approved derived antibody | OmniAb
| OmniAb
See More
OmniAb
Investor Conference Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Royalty
Antibody discovery
Recent decks by OmniAb
Results
March 2024
Investor Presentation
August 2023
Results
August 2023
Investor Presentation
May 2023
See all presentations by OmniAb (9 decks)
Related decks
AbCellera
Results
November 2022
AbCellera
Investor Presentation
July 2022
Evotec
Investor Presentation
July 2022
AbCellera
Results
February 2023
Theravance Biopharma
Results
February 2023
AbCellera
Investor Conference
September 2021
Alkermes
Results
February 2023
Absci
Investor Presentation
May 2022
Recent decks by OmniAb
See all presentations (9 decks)
Results
March 2024
Investor Presentation
August 2023
Results
August 2023
Investor Presentation
May 2023
AbCellera
Results
November 2022
AbCellera
Investor Presentation
July 2022
Evotec
Investor Presentation
July 2022
AbCellera
Results
February 2023
Theravance Biopharma
Results
February 2023
AbCellera
Investor Conference
September 2021
Alkermes
Results
February 2023
Absci
Investor Presentation
May 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io